Efficacy of intermediate-dose oral erythromycin on very low birth weight infants with feeding intolerance

Pediatrics and Neonatology
Yan-Yan NgHua-Pin Chang

Abstract

Erythromycin is generally used as a prokinetic agent for the treatment of feeding intolerance in preterm infants; however, results from previous studies significantly vary due to different medication dosages, routes of administration, and therapy durations. The effectiveness and safety of intermediate-dose oral erythromycin in very low birth weight (VLBW) infants with feeding intolerance was examined in this study. Between November 2007 and August 2009, 45 VLBW infants with feeding intolerance, who were all at least 14 days old, were randomly allocated to a treatment group and administered 5mg/kg oral erythromycin every 6hours for 14 days (n=19). Another set of randomly selected infants was allocated to the control group, which was not administered erythromycin (n=26). The number of days required to achieve full enteral feeding (36.5±7.4 vs. 54.7±23.3 days, respectively; p=0.01), the duration of parenteral nutrition (p<0.05), and the time required to achieve a body weight ≥2500g (p<0.05) were significantly shorter in the erythromycin group compared with the control group. The incidence of parenteral nutrition-associated cholestasis (PNAC) and necrotizing enterocolitis (NEC) ≥ stage II after 14 days of treatment were significant...Continue Reading

References

Nov 1, 1989·JPEN. Journal of Parenteral and Enteral Nutrition·R A Drongowski, A G Coran
Apr 9, 1999·Archives of Disease in Childhood. Fetal and Neonatal Edition·B J StensonA J Lyon
Mar 10, 2001·Clinics in Liver Disease·G A Kullak-Ublick, P J Meier
Apr 26, 2001·Archives of Disease in Childhood. Fetal and Neonatal Edition·P C NgA F Cheng
Jul 2, 2002·Archives of Pediatrics & Adolescent Medicine·William O CooperWayne A Ray
Oct 17, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Manfred Hauben, Guy W Amsden
Feb 4, 2005·Pediatric Cardiology·C M G Rocha, M M Barbosa
Apr 29, 2005·International Journal of Clinical Practice·S K Patole, R Muller
May 14, 2005·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Uluc YisNurettin Unal
May 19, 2005·Archives of Disease in Childhood. Fetal and Neonatal Edition·S PatoleD Doherty
Aug 18, 2005·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Sanjay Patole
Dec 20, 2005·Lancet·Anne Hardy
Jun 2, 2006·The Journal of Pediatrics·Pracha NuntnarumitSuppawat Boonkasidecha
Oct 13, 2006·Journal of Perinatology : Official Journal of the California Perinatal Association·H AlyN El-Badry
Feb 10, 2007·The Journal of Antimicrobial Chemotherapy·Catherine V Hawkyard, Roland J Koerner
Nov 6, 2007·The Journal of Antimicrobial Chemotherapy·Adam Deane, Robert Young
Oct 23, 2008·The Journal of Pediatrics·Kathryn K Collins, Judith M Sondheimer
Jul 16, 2009·Italian Journal of Pediatrics·Valentina Bozzetti, Paolo Tagliabue
Oct 28, 2009·Pediatrics and Neonatology·Meng-Han HsiehHsiu-Lin Chen
Apr 11, 2013·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Tulin GokmenUgur Dilmen
Dec 20, 2013·Clinical Pharmacology : Advances and Applications·Arthur E Frankel

❮ Previous
Next ❯

Citations

Jul 3, 2015·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Selim SancakFahri Ovalı
Jan 13, 2015·Nutrients·Sourabh DuttaChristoph Fusch
Feb 22, 2012·Pediatrics and Neonatology·Chung-Ming Chen
Sep 16, 2015·The Journal of Pediatrics·Elizabeth T RogawskiGagandeep Kang
Oct 3, 2015·Italian Journal of Pediatrics·Carlo DaniUNKNOWN Task Force for Hyperbilirubinemia of the Italian Society of Neonatology
Jul 24, 2013·Gastroenterology Research and Practice·Luigi CorvagliaGiacomo Faldella
Mar 5, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M MillionM Paul
Dec 29, 2016·Pediatric Surgery International·Noora H Al-Shahwani, David L Sigalet
Jul 10, 2018·Journal of Pediatric Gastroenterology and Nutrition·Cortney R BallengeeDavid A Kaufman
Feb 14, 2018·Neonatal Network : NN·Sara E Rostas, Christopher McPherson
Oct 26, 2013·American Journal of Physiology. Gastrointestinal and Liver Physiology·Michael L JensenPer T Sangild
Mar 26, 2015·Journal of Pediatric Gastroenterology and Nutrition·Jessica E EricsonUNKNOWN Best Pharmaceuticals for Children Act–Pediatric Trials Network Administrative Core Committee
Sep 3, 2020·NeoReviews·Jennifer Fundora, Susan W Aucott
Feb 16, 2016·Diabetes, Obesity & Metabolism·K P EconomopoulosR A Hodin
Jun 26, 2021·Pediatrics and Neonatology·Pattarapan SukwuttichaiNawaporn Vimolsarawong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.